Last updated on July 2020

Memory Improvement Through Nicotine Dosing (MIND) Study


Brief description of study

The purpose of the study is to see if daily transdermal nicotine is able to produce a significant cognitive, clinical and functional improvement in participants with MCI. Neuronal nicotinic receptors have long been known to play a critical role in memory function in preclinical studies, with nicotine improving attention, learning, and memory function.

The study will enroll 300 participants for a 2 year period. Participants will be randomized (50:50) to either the transdermal nicotine, beginning at 7mg/day, and increasing to 21mg/day, or placebo skin patch.

Clinical Study Identifier: NCT02720445

Find a site near you

Start Over

Central Arkansas Veterans Healthcare System

North Little Rock, AR United States
4.63miles
  Connect »

Central Arkansas Veterans HS

North Little Rock, AR United States
5.15miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.